Janne M. Moll

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels.

Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels.

Journal: Gut microbes
Published: June 25, 2026

Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide.

Investigation of the stool microbiome of short bowel syndrome patients before and after a 24-week treatment with the glucagon-like peptide 2 analog glepaglutide.

Journal: Clinical nutrition ESPEN
Published: February 05, 2026

Impact of Bifidobacterium infantis supplementation on growth, health outcomes, and gut microbiome features in underweight infants from Pakistan.

Impact of Bifidobacterium infantis supplementation on growth, health outcomes, and gut microbiome features in underweight infants from Pakistan.

Journal: Frontiers in nutrition
Published: January 07, 2026

Early-life immune imprinting by a B. infantis-HMO synbiotic shapes infant immune signatures and protects against experimental respiratory disease.

Early-life immune imprinting by a B. infantis-HMO synbiotic shapes infant immune signatures and protects against experimental respiratory disease.

Journal: Cell reports. Medicine
Published: August 06, 2025

Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.

Correction: Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.

Journal: Frontiers in nutrition
Published: July 30, 2025

Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.

Partially hydrolyzed, whey-based infant formula with six human milk oligosaccharides, B. infantis LMG11588, and B. lactis CNCM I-3446 is safe, well tolerated, and improves gut health: a staged analysis of a randomized trial.

Journal: Frontiers in nutrition
Published: May 14, 2025

Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization.

Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization.

Journal: Nature microbiology
Published: April 26, 2025

A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial.

A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial.

Journal: Nature communications
Published: April 15, 2025

Author Correction: Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial.

Author Correction: Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial.

Journal: Nature communications
Published: April 10, 2025

Temporal dynamics and microbial interactions shaping the gut resistome in early infancy.

Temporal dynamics and microbial interactions shaping the gut resistome in early infancy.

Journal: Nature communications
Published: January 14, 2025

Shifts in Infant Skin Microbiome at 2 Months after Short-Term Emollient Use from Birth Are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.

Shifts in Infant Skin Microbiome at 2 Months after Short-Term Emollient Use from Birth Are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.

Journal: The Journal of investigative dermatology
Published: December 02, 2024

The HUNT study identifies host genetic factors reproducibly associated with human gut microbiota composition.

The HUNT study identifies host genetic factors reproducibly associated with human gut microbiota composition.

Journal: Nature genetics
Published: August 28, 2024
Showing 1-12 of 26

Last Updated: 09/26/2026